Johnson & Johnson Recalls Baby Powder Due To Asbestos ConcernsJohnson & Johnson announced on Friday that it's initiating a voluntary recall in the United States of its popular Johnson's Baby Powder due to low levels of asbestos contamination.
Attorney General Frosh Announces $116M Multistate Settlement with Johnson & Johnson and Ethicon, Inc.Maryland Attorney General Brian E. Frosh announced a multistate settlement with Johnson & Johnson and its subsidiary Ethicon, Inc.
Maryland Man Wins $8B In Johnson & Johnson Verdict Over Risperdal Linked To Boy Growing BreastsA Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys.
Johnson & Johnson Opioid Lawsuit Could Benefit MarylandMaryland's Attorney General Brian Frosh said the state may benefit after a judge found Johnson & Johnson guilty of fueling the opioid epidemic in Oklahoma.
Johnson & Johnson Says U.S. Investigating Johnson's Baby PowderJohnson & Johnson said the Justice Department and U.S. Securities and Exchange Commission are investigating the company amid allegations Johnson's Baby Powder is contaminated with asbestos, a mineral linked to cancer.
Judge Tosses $417M Award Against Johnson & JohnsonA judge on Friday tossed out a $417 million jury award to a woman who claimed she developed ovarian cancer by using Johnson & Johnson talc-based baby powder for feminine hygiene.
Appeals Court Tosses $72 Million Award In Talcum Powder CaseA Missouri appeals court on Tuesday threw out a $72 million award to a woman who claimed talcum powder made by Johnson & Johnson contributed to her ovarian cancer.
Record $417M Award In Lawsuit Linking Baby Powder To CancerA jury ordered Johnson & Johnson to pay a record $417 million to a woman who claimed that the talc in the company's baby powder causes ovarian cancer.
FDA Advisers Unanimously Back Johnson & Johnson Hepatitis C DrugAn experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government advisers who say the medication should be approved to treat patients infected with the liver-destroying virus.